Related references
Note: Only part of the references are listed.Novel Therapies for Hepatitis C: Insights from the Structure of the Virus
Dahlene N. Fusco et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Multiple Mutations in Hepatitis C Virus NS5A Domain II Are Required To Confer a Significant Level of Resistance to Alisporivir
Jose A. Garcia-Rivera et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2012)
ALISPORIVIR (ALV) PLUS PEG-INTERFERON/RIBAVIRIN (PR) IN HCV G1 TREATMENT-EXPERIENCED PATIENTS ACHIEVES PRIMARY ENDPOINT WITH SUPERIOR EFFICACY AT TREATMENT WEEK 12 COMPARED TO RETREATMENT WITH PR
A. Alberti et al.
JOURNAL OF HEPATOLOGY (2012)
ALISPORIVIR PLUS RIBAVIRIN IS HIGHLY EFFECTIVE AS INTERFERON-FREE OR INTERFERON-ADD-ON REGIMEN IN PREVIOUSLY UNTREATED HCV-GT2 OR GT3 PATIENTS: SVR12 RESULTS FROM VITAL-1 PHASE 2B STUDY
J. -M. Pawlotsky et al.
JOURNAL OF HEPATOLOGY (2012)
The cyclophilin inhibitor SCY-635 suppresses viral replication and induces endogenous interferons in patients with chronic HCV genotype 1 infection
Sam Hopkins et al.
JOURNAL OF HEPATOLOGY (2012)
Preclinical Characterization of Naturally Occurring Polyketide Cyclophilin Inhibitors from the Sanglifehrin Family
Matthew A. Gregory et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Safety, pharmacokinetics, and antiviral activity of the cyclophilin inhibitor NIM811 alone or in combination with pegylated interferon in HCV-infected patients receiving 14 days of therapy
Eric Lawitz et al.
ANTIVIRAL RESEARCH (2011)
Cyclophilin A Interacts with Domain II of Hepatitis C Virus NS5A and Stimulates RNA Binding in an Isomerase-Dependent Manner
Toshana L. Foster et al.
JOURNAL OF VIROLOGY (2011)
EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy
Joachim Lupberger et al.
NATURE MEDICINE (2011)
A Cell-Based Assay for RNA Synthesis by the HCV Polymerase Reveals New Insights on Mechanism of Polymerase Inhibitors and Modulation by NS5A
C. T. Ranjith-Kumar et al.
PLOS ONE (2011)
Mechanism of Resistance of Hepatitis C Virus Replicons to Structurally Distinct Cyclophilin Inhibitors
Xiaoling Puyang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Cyclophilin A-independent recruitment of NS5A and NS5B into hepatitis C virus replication complexes
Udayan Chatterji et al.
JOURNAL OF GENERAL VIROLOGY (2010)
HCV resistance to cyclosporin A does not correlate with a resistance of the NS5A-cyclophilin A interaction to cyclophilin inhibitors
Udayan Chatterji et al.
JOURNAL OF HEPATOLOGY (2010)
The use of AlphaLISA technology to detect interaction between hepatitis C virus-encoded NS5A and cyclophilin A
Helen Waller et al.
JOURNAL OF VIROLOGICAL METHODS (2010)
Cyclosporine Inhibits a Direct Interaction between Cyclophilins and Hepatitis C NS5A
Fiona Fernandes et al.
PLOS ONE (2010)
DEB025 (Alisporivir) Inhibits Hepatitis C Virus Replication by Preventing a Cyclophilin A Induced Cis-Trans Isomerisation in Domain II of NS5A
Lotte Coelmont et al.
PLOS ONE (2010)
Multiple cyclophilins involved in different cellular pathways mediate HCV replication
L. Alex Gaither et al.
VIROLOGY (2010)
A Major Determinant of Cyclophilin Dependence and Cyclosporine Susceptibility of Hepatitis C Virus Identified by a Genetic Approach
Feng Yang et al.
PLOS PATHOGENS (2010)
The Cyclophilin Inhibitor Debio 025 Combined with PEG IFNα2a Significantly Reduces Viral Load in Treatment-Naive Hepatitis C Patients
Robert Flisiak et al.
HEPATOLOGY (2009)
Calmodulin-dependent phosphatase, kinases, and transcriptional corepressors involved in T-cell activation
Jun O. Liu
IMMUNOLOGICAL REVIEWS (2009)
Hepatitis C Virus NS5A Protein Is a Substrate for the Peptidyl-prolyl cis/trans Isomerase Activity of Cyclophilins A and B
Xavier Hanoulle et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication
Udayan Chatterji et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
EFFICACY AND SAFETY OF THE CYCLOPHILIN INHIBITOR DEBIO 025 IN COMBINATION WITH PEGYLATED INTERFERON ALPHA-2A AND RIBAVIRIN IN PREVIOUSLY NULL-RESPONDER GENOTYPE 1 HCV PATIENTS
D. R. Nelson et al.
JOURNAL OF HEPATOLOGY (2009)
Critical Role of Cyclophilin A and Its Prolyl-Peptidyl Isomerase Activity in the Structure and Function of the Hepatitis C Virus Replication Complex
Zhe Liu et al.
JOURNAL OF VIROLOGY (2009)
Essential Role of Cyclophilin A for Hepatitis C Virus Replication and Virus Production and Possible Link to Polyprotein Cleavage Kinetics
Artur Kaul et al.
PLOS PATHOGENS (2009)
The cyclophilin inhibitor debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus
Robert Flisiak et al.
HEPATOLOGY (2008)
Cyclophilin A is an essential cofactor for hepatitis C virus infection and the principal mediator of cyclosporine resistance in vitro
Feng Yang et al.
JOURNAL OF VIROLOGY (2008)
Sensitivity of hepatitis C virus to cyclosporine a depends on nonstructural proteins NS5A and NS5B
Fiona Fernandes et al.
HEPATOLOGY (2007)
Characterization of hepatitis c virus subgenomic replicon resistance to cyclosporine in vitro
John M. Robida et al.
JOURNAL OF VIROLOGY (2007)
NIM811, a cyclophilin inhibitor, exhibits potent in vitro activity against hepatitis C virus alone or in combination with alpha interferon
Sue Ma et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Evaluation of the anti-hepatitis C virus effects of cyclophilin inhibitors, cyclosporin A, and NIM811
K Goto et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Diverse effects of cyclosporine on hepatitis C virus strain replication
N Ishii et al.
JOURNAL OF VIROLOGY (2006)
The non-immunosuppressive cyclosporin DEBIO-025 is a potent inhibitor of hepatitis C virus replication in vitro
J Paeshuyse et al.
HEPATOLOGY (2006)
Suppression of hepatitis C virus replication by cyclosporin A is mediated by blockade of cyclophilins
M Nakagawa et al.
GASTROENTEROLOGY (2005)
Production of infectious hepatitis C virus in tissue culture from a cloned viral genome
T Wakita et al.
NATURE MEDICINE (2005)
Cyclophilin A-deficient mice are resistant to immunosuppression by cyclosporine
J Colgan et al.
JOURNAL OF IMMUNOLOGY (2005)
Specific inhibition of hepatitis C virus replication by cyclosporin A
M Nakagawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2004)
Disruption of hepatitis C virus RNA replication through inhibition of host protein geranylgeranylation
J Ye et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Cyclosporin A suppresses replication of hepatitis C virus genome in cultured hepatocytes
K Watashi et al.
HEPATOLOGY (2003)
Hepatitis C virus (HCV) NS5A binds RNA-dependent RNA polymerase (RdRP) NS5B and modulates RNA-dependent RNA polymerase activity
Y Shirota et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Cyclophilin A regulates HIV-1 infectivity, as demonstrated by gene targeting in human T cells
D Braaten et al.
EMBO JOURNAL (2001)
Share Paper
